An AllTrials project

NCT07410455: An ongoing trial by Can-Fite BioPharma

This trial is ongoing. It must report results 1 year, 10 months from now.

Full data

Full entry on ClinicalTrials.gov NCT07410455
Title An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date June 1, 2026
Completion date Aug. 31, 2027
Required reporting date Aug. 30, 2028, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Oct. 21, 2026
Days late None